Literature DB >> 24760888

Mutations in HIV-1 reverse transcriptase affect the errors made in a single cycle of viral replication.

Michael E Abram1, Andrea L Ferris1, Kalyan Das2, Octavio Quinoñes3, Wei Shao4, Steven Tuske2, W Gregory Alvord3, Eddy Arnold2, Stephen H Hughes5.   

Abstract

UNLABELLED: The genetic variation in HIV-1 in patients is due to the high rate of viral replication, the high viral load, and the errors made during viral replication. Some of the mutations in reverse transcriptase (RT) that alter the deoxynucleoside triphosphate (dNTP)-binding pocket, including those that confer resistance to nucleoside/nucleotide analogs, affect dNTP selection during replication. The effects of mutations in RT on the spectrum (nature, position, and frequency) of errors made in vivo are poorly understood. We previously determined the mutation rate and the frequency of different types of mutations and identified hot spots for mutations in a lacZα (the α complementing region of lacZ) reporter gene carried by an HIV-1 vector that replicates using wild-type RT. We show here that four mutations (Y115F, M184V, M184I, and Q151M) in the dNTP-binding pocket of RT that had relatively small effects on the overall HIV-1 mutation rate (less than 3-fold compared to the wild type) significantly increased mutations at some specific positions in the lacZα reporter gene. We also show that changes in a sequence that flanks the reporter gene can affect the mutations that arise in the reporter. These data show that changes either in HIV-1 RT or in the sequence of the nucleic acid template can affect the spectrum of mutations made during viral replication. This could, by implication, affect the generation of drug-resistant mutants and immunological-escape mutants in patients. IMPORTANCE: RT is the viral enzyme that converts the RNA genome of HIV into DNA. Errors made during replication allow the virus to escape from the host's immune system and to develop resistance to the available anti-HIV drugs. We show that four different mutations in RT which are known to be associated with resistance to anti-RT drugs modestly increased the overall frequency of errors made during viral replication. However, the increased errors were not uniformly distributed; the additional errors occurred at a small number of positions (hot spots). Moreover, some of the RT mutations preferentially affected the nature of the errors that were made (some RT mutations caused an increase in insertion and deletion errors; others caused an increase in substitution errors). We also show that sequence changes in a region adjacent to a target gene can affect the errors made within the target gene.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24760888      PMCID: PMC4054409          DOI: 10.1128/JVI.00302-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  77 in total

1.  The fidelity of reverse transcription differs in reactions primed with RNA versus DNA primers.

Authors:  B B Oude Essink; B Berkhout
Journal:  J Biomed Sci       Date:  1999 Mar-Apr       Impact factor: 8.410

2.  Molecular basis of beta-galactosidase alpha-complementation.

Authors:  K E Langley; M R Villarejo; A V Fowler; P J Zamenhof; I Zabin
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

3.  Forward mutation rate of human immunodeficiency virus type 1 in a T lymphoid cell line.

Authors:  L M Mansky
Journal:  AIDS Res Hum Retroviruses       Date:  1996-03-01       Impact factor: 2.205

4.  Hypermutation at the immunoglobulin heavy chain locus in a pre-B-cell line.

Authors:  M Wabl; P D Burrows; A von Gabain; C Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  Mutational studies of human immunodeficiency virus type 1 reverse transcriptase: the involvement of residues 183 and 184 in the fidelity of DNA synthesis.

Authors:  M Bakhanashvili; O Avidan; A Hizi
Journal:  FEBS Lett       Date:  1996-08-12       Impact factor: 4.124

6.  Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.

Authors:  N K Back; M Nijhuis; W Keulen; C A Boucher; B O Oude Essink; A B van Kuilenburg; A H van Gennip; B Berkhout
Journal:  EMBO J       Date:  1996-08-01       Impact factor: 11.598

7.  Mechanistic studies examining the efficiency and fidelity of DNA synthesis by the 3TC-resistant mutant (184V) of HIV-1 reverse transcriptase.

Authors:  J Y Feng; K S Anderson
Journal:  Biochemistry       Date:  1999-07-20       Impact factor: 3.162

8.  Concomitant combination therapy for HIV infection preferable over sequential therapy with 3TC and non-nucleoside reverse transcriptase inhibitors.

Authors:  J Balzarini; H Pelemans; A Karlsson; E De ClercQ; J P Kleim
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

9.  The base substitution fidelity of eucaryotic DNA polymerases. Mispairing frequencies, site preferences, insertion preferences, and base substitution by dislocation.

Authors:  T A Kunkel; P S Alexander
Journal:  J Biol Chem       Date:  1986-01-05       Impact factor: 5.157

10.  Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase.

Authors:  M A Wainberg; W C Drosopoulos; H Salomon; M Hsu; G Borkow; M Parniak; Z Gu; Q Song; J Manne; S Islam; G Castriota; V R Prasad
Journal:  Science       Date:  1996-03-01       Impact factor: 47.728

View more
  23 in total

1.  Picomolar to Micromolar: Elucidating the Role of Distal Mutations in HIV-1 Protease in Conferring Drug Resistance.

Authors:  Mina Henes; Gordon J Lockbaum; Klajdi Kosovrasti; Florian Leidner; Gily S Nachum; Ellen A Nalivaika; Sook-Kyung Lee; Ean Spielvogel; Shuntai Zhou; Ronald Swanstrom; Daniel N A Bolon; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  ACS Chem Biol       Date:  2019-08-13       Impact factor: 5.100

2.  Near-Full-Length Genetic Characterization of a Novel HIV-1 Unique Recombinant with Similarities to A1, CRF01_AE, and CRFO2_AG Viruses in Yaoundé, Cameroon.

Authors:  Arpan Acharya; Julius Y Fonsah; Dora Mbanya; Alfred K Njamnshi; Georgette D Kanmogne
Journal:  AIDS Res Hum Retroviruses       Date:  2019-04-16       Impact factor: 2.205

3.  Yet Another Quick Assembly, Analysis and Trimming Tool (YAQAAT): A Server for the Automated Assembly and Analysis of Sanger Sequencing Data.

Authors:  Darius Wen-Shuo Koh; Kwok-Fong Chan; Weiling Wu; Samuel Ken-En Gan
Journal:  J Biomol Tech       Date:  2021-01-15

4.  Molecular Determinants of Epistasis in HIV-1 Protease: Elucidating the Interdependence of L89V and L90M Mutations in Resistance.

Authors:  Mina Henes; Klajdi Kosovrasti; Gordon J Lockbaum; Florian Leidner; Gily S Nachum; Ellen A Nalivaika; Daniel N A Bolon; Nese Kurt Yilmaz; Celia A Schiffer; Troy W Whitfield
Journal:  Biochemistry       Date:  2019-08-19       Impact factor: 3.162

Review 5.  Reverse Transcription of Retroviruses and LTR Retrotransposons.

Authors:  Stephen H Hughes
Journal:  Microbiol Spectr       Date:  2015-04

Review 6.  CRISPR/Cas9 and Genome Editing for Viral Disease-Is Resistance Futile?

Authors:  Harshana S De Silva Feelixge; Daniel Stone; Pavitra Roychoudhury; Martine Aubert; Keith R Jerome
Journal:  ACS Infect Dis       Date:  2018-03-21       Impact factor: 5.084

7.  Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors.

Authors:  Anna Schneider; Angela Corona; Imke Spöring; Mareike Jordan; Bernd Buchholz; Elias Maccioni; Roberto Di Santo; Jochen Bodem; Enzo Tramontano; Birgitta M Wöhrl
Journal:  Nucleic Acids Res       Date:  2016-02-04       Impact factor: 16.971

8.  Oregano Oil and Its Principal Component, Carvacrol, Inhibit HIV-1 Fusion into Target Cells.

Authors:  S Mediouni; J A Jablonski; S Tsuda; A Barsamian; C Kessing; A Richard; A Biswas; F Toledo; V M Andrade; Y Even; M Stevenson; T Tellinghuisen; H Choe; M Cameron; T D Bannister; S T Valente
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

9.  Resolution of Specific Nucleotide Mismatches by Wild-Type and AZT-Resistant Reverse Transcriptases during HIV-1 Replication.

Authors:  Siarhei Kharytonchyk; Steven R King; Clement B Ndongmo; Krista L Stilger; Wenfeng An; Alice Telesnitsky
Journal:  J Mol Biol       Date:  2016-04-10       Impact factor: 5.469

10.  Lentiviral-Driven Discovery of Cancer Drug Resistance Mutations.

Authors:  Paul Yenerall; Rahul K Kollipara; Kimberley Avila; Michael Peyton; Christopher A Eide; Daniel Bottomly; Shannon K McWeeney; Yan Liu; Kenneth D Westover; Brian J Druker; John D Minna; Ralf Kittler
Journal:  Cancer Res       Date:  2021-07-23       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.